Hexa Reports Industry Pneumonia Therapeutics Market | Page 2
In the present scenario, there are 12 drugs under investigation in phase III trials, 4 drugs under phase II, and 3
drugs under phase I trial. The aforementioned factors exemplify the consistent efforts being made by the
market players. For instance, Omadacycline, a tetracycline under phase III clinical trial, developed by Paratek
Pharmaceuticals is being investigated for use in the treatment of ventilator-associated and community-
acquired bacterial pneumonia.
Further key findings from the report suggest:
Vaccines accounted for the largest share in the product segment in 2016. This can be attributed to
their high efficacy and growing inclination of patients toward preventive measures
They are also expected to grow at a lucrative rate owing to the recommendation by WHO for their
inclusion in national immunization programs
Drugs are expected to witness moderate growth rate throughout the forecast period. This is believed
to be a result of the infiltration of generic drugs that are more cost-efficient.
North America accounted fora substantial share in the market owing toincreasing number of
supportive government initiatives and high awareness levels amongst the end-users
Asia Pacific is expected to witness exponential CAGR during the forecast period owing to its high
disease burden and continual infrastructural upgradation of research & manufacturing facilities in the
region
High competition has been observed in the market, where major players adopt strategies such as new
product development, collaborations,and strategic agreements to gain market share
Request A Sample copy of This Report @
https://www.hexareports.com/report/pneumonia-therapeutics-market/request-sample
Table Of Content
Chapter 1 Research Methodology & Scope
1.1 Region-wise Market Calculation
1.2 Region-based Segment Share Calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Region Wise Market Calculation
Chapter 3 Pneumonia Therapeutics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
Follow Us: